166 related articles for article (PubMed ID: 20139272)
1. Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity.
Haque A; Stanley AC; Amante FH; Rivera Fde L; Zhou Y; Kuns RD; Yardley V; Sakaguchi S; Hill GR; Engwerda CR
J Immunol; 2010 Mar; 184(5):2583-92. PubMed ID: 20139272
[TBL] [Abstract][Full Text] [Related]
2. Resistance of regulatory T cells to glucocorticoid-induced [corrected] TNFR family-related protein (GITR) during Plasmodium yoelii infection.
Hisaeda H; Hamano S; Mitoma-Obata C; Tetsutani K; Imai T; Waldmann H; Himeno K; Yasutomo K
Eur J Immunol; 2005 Dec; 35(12):3516-24. PubMed ID: 16304635
[TBL] [Abstract][Full Text] [Related]
3. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.
Mitsui J; Nishikawa H; Muraoka D; Wang L; Noguchi T; Sato E; Kondo S; Allison JP; Sakaguchi S; Old LJ; Kato T; Shiku H
Clin Cancer Res; 2010 May; 16(10):2781-91. PubMed ID: 20460483
[TBL] [Abstract][Full Text] [Related]
4. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific crosslinking of GITR as costimulation for immunotherapy.
Burckhart T; Thiel M; Nishikawa H; Wüest T; Müller D; Zippelius A; Ritter G; Old L; Shiku H; Renner C
J Immunother; 2010; 33(9):925-34. PubMed ID: 20948444
[TBL] [Abstract][Full Text] [Related]
6. In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1.
La S; Kim E; Kwon B
Exp Mol Med; 2005 Jun; 37(3):193-8. PubMed ID: 16000873
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis.
Patel M; Xu D; Kewin P; Choo-Kang B; McSharry C; Thomson NC; Liew FY
Eur J Immunol; 2005 Dec; 35(12):3581-90. PubMed ID: 16285015
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.
Shimizu J; Yamazaki S; Takahashi T; Ishida Y; Sakaguchi S
Nat Immunol; 2002 Feb; 3(2):135-42. PubMed ID: 11812990
[TBL] [Abstract][Full Text] [Related]
9. A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes.
Maxeiner JH; Karwot R; Sauer K; Scholtes P; Boross I; Koslowski M; Türeci O; Wiewrodt R; Neurath MF; Lehr HA; Finotto S
Cancer Res; 2009 Apr; 69(7):3069-76. PubMed ID: 19318584
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen-specific CD8+ T cells with tumor regression.
Imai N; Ikeda H; Tawara I; Wang L; Wang L; Nishikawa H; Kato T; Shiku H
Cancer Sci; 2009 Jul; 100(7):1317-25. PubMed ID: 19432889
[TBL] [Abstract][Full Text] [Related]
11. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
[TBL] [Abstract][Full Text] [Related]
12. CD40 signaling in CD8+CD40+ T cells turns on contra-T regulatory cell functions.
Martin S; Pahari S; Sudan R; Saha B
J Immunol; 2010 May; 184(10):5510-8. PubMed ID: 20400702
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
Ko K; Yamazaki S; Nakamura K; Nishioka T; Hirota K; Yamaguchi T; Shimizu J; Nomura T; Chiba T; Sakaguchi S
J Exp Med; 2005 Oct; 202(7):885-91. PubMed ID: 16186187
[TBL] [Abstract][Full Text] [Related]
14. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of murine gammadelta lymphocyte expansion and effector function by regulatory alphabeta T cells is cell-contact-dependent and sensitive to GITR modulation.
Gonçalves-Sousa N; Ribot JC; deBarros A; Correia DV; Caramalho I; Silva-Santos B
Eur J Immunol; 2010 Jan; 40(1):61-70. PubMed ID: 19877017
[TBL] [Abstract][Full Text] [Related]
16. GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice.
Santucci L; Agostini M; Bruscoli S; Mencarelli A; Ronchetti S; Ayroldi E; Morelli A; Baldoni M; Riccardi C
Gut; 2007 Jan; 56(1):52-60. PubMed ID: 16763055
[TBL] [Abstract][Full Text] [Related]
17. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
18. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
[TBL] [Abstract][Full Text] [Related]
19. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K
Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075
[TBL] [Abstract][Full Text] [Related]
20. GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo.
van Olffen RW; Koning N; van Gisbergen KP; Wensveen FM; Hoek RM; Boon L; Hamann J; van Lier RA; Nolte MA
J Immunol; 2009 Jun; 182(12):7490-500. PubMed ID: 19494272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
